| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.099 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |